Siemens Healthineers will utilize ALZpath’s high-performing, proprietary pTau217 antibody in its growing test menu for its Atellica analyzers to enable IVD testing for Alzheimer’s disease CARLSBAD, Calif., Dec. 15, 2025 /PRNewswire/ — ALZpath, Inc., a leading developer of innovative…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
